Arvind Panagariya is an Indian-American economist and a professor of economics at Columbia University, who served as first vice-chairman of the government of India think-tank NITI Aayog between January 2015 and August 2017. Read More
After All India Institute of Medical Sciences (AIIMS), Patna, now AIIMS Delhi is also planning to start the Paediatric clinical trials of the indigenous Bharat Biotech's COVID-19 vaccine "Covaxin" in few days, sources said on Thursday. ...
In the third edition of the Niti Aayog's Sustainable Development Goals (SDG) India Index 2020-21 released on Thursday, Kerala has retained the top rank with a score of 75 while Bihar has been adjudged as the worst performer with a score of 52. ...
Patna's All India Institute of Medical Sciences (AIIMS) has started the paediatric trials for the COVID-19 vaccine manufactured by the Bharat Biotech, Covaxin. ...
The situation created by COVID-19 "is stabilising in a major part of the country" with the positivity rate and active cases going down, VK Paul, Member (Health), Niti Aayog, said on Saturday. ...
Noting that the strategy of starting the COVID-19 vaccination programme with frontline warriors has paid rich dividends in the second wave, Prime Minister Narendra Modi said on Monday that the vaccines have ensured the safety of most of the doctors a ...
Karnataka will soon have a manufacturing plant of Bharat Biotech's Covaxin in Maluru industrial area, near Kolara district, said Deputy Chief Minister and State COVID task force head Dr C N Ashwatha Narayana on Friday. ...
